HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Seeks Speedier Seizure, Injunction Decisions Via Protocol Changes

This article was originally published in The Rose Sheet

Executive Summary

FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.

You may also be interested in...

FDA's New ORA Head, Dara Corrigan, Has Broad Enforcement Experience

Former acting HHS inspector general will become associate commissioner for regulatory affairs two years after Margaret O'Keeffe Glavin's retirement.

Hamburg Offers "Close Out" Carrot To Firms In Plan To Accelerate Enforcement

FDA enforcement initiative eliminates requirement for all warning letters to be reviewed by Office of Chief Counsel.

US Researchers Working Toward Universal Coronavirus Vaccine

The SARS-CoV-2 outbreak has the federal government working not only on a vaccine candidate specifically targeted at the novel coronavirus but also thinking more broadly about ways to head off future potential pandemics with emerging pathogens.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts